Dietary Trials and Gut Candidate Phyla Radiation Bacteria: The Effect of Placebo on the Prevalence of Saccharibacteria in Healthy Armenian Women and Women with Familial Mediterranean Fever DOI
Natalya Harutyunyan, Lena Stepanyan, Lena Malkhasyan

et al.

AgriScience and Technology, Journal Year: 2024, Volume and Issue: unknown, P. 345 - 353

Published: Jan. 1, 2024

“Candidate Phyla Radiation” (CPR) bacteria, representing ~15 % of bacterial diversity and over 70 phyla, are extremely small bacteria that primarily survive in parasitic or symbiotic forms. CPR including Candidatus Brownbacteria, Hugbacteria, Saccharibacteria (formerly TM7), were first identified humans 2007. They linked to the microbiota healthy diseased individuals, being present oral cavity, gastrointestinal, reproductive tracts. such as Saccharibacteria, associated with dysbiotic conditions like periodontitis can act pathogens potential protectors against inflammatory damage caused by host-associated bacteria.This study aimed assess effect a placebo on gut Armenian women those Familial Mediterranean Fever (FMF) disease, condition high prevalence Armenia often disturbances. Stool samples analyzed using culture-independent, high-density DNA microarray method, statistical analyses performed Multibase 2015 Excel Add-in program (NumericalDynamics, Tokyo, Japan). Results indicate respond variably depending health status, some showing significant quantitative qualitative changes while others remained unchanged. In conclusion, this confirms presence both FMF. The distinct responses intestinal highlight importance placebo-controlled trials research. Furthermore, findings emphasize role gut-brain processes their implications disease.

Language: Английский

Gut–Brain Axis and Neuroinflammation: The Role of Gut Permeability and the Kynurenine Pathway in Neurological Disorders DOI Creative Commons
Rowan Kearns

Cellular and Molecular Neurobiology, Journal Year: 2024, Volume and Issue: 44(1)

Published: Oct. 8, 2024

The increasing prevalence of neurological disorders such as Alzheimer's, Parkinson's, and multiple sclerosis presents a significant global health challenge. Despite extensive research, the precise mechanisms underlying these conditions remain elusive, with current treatments primarily addressing symptoms rather than root causes. Emerging evidence suggests that gut permeability kynurenine pathway are involved in pathogenesis conditions, offering promising targets for novel therapeutic preventive strategies. Gut refers to intestinal lining's ability selectively allow essential nutrients into bloodstream while blocking harmful substances. Various factors, including poor diet, stress, infections, genetic predispositions, can compromise integrity, leading increased permeability. This condition facilitates translocation toxins bacteria systemic circulation, triggering widespread inflammation impacts via gut-brain axis. axis (GBA) is complex communication network between central nervous system. Dysbiosis, an imbalance microbiota, increase inflammation, exacerbating neuroinflammation-a key factor disorders. pathway, primary route tryptophan metabolism, significantly implicated this process. Dysregulation context leads production neurotoxic metabolites, quinolinic acid, which contribute neuronal damage progression narrative review highlights potential progress understanding mechanisms. Interventions targeting maintaining balanced microbiota through probiotics, lifestyle modifications show promise reducing neuroinflammation supporting brain health. In addition, pharmacological approaches aimed at modulating directly, inhibitors indoleamine 2,3-dioxygenase, offer avenues new treatments. Understanding interconnected pathways crucial developing effective strategies prevent manage

Language: Английский

Citations

21

Microbiota, Tryptophan and Aryl Hydrocarbon Receptors as the Target Triad in Parkinson’s Disease—A Narrative Review DOI Open Access
Paulina Iwaniak,

Maja Owe-Larsson,

Ewa M. Urbańska

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(5), P. 2915 - 2915

Published: March 2, 2024

In the era of a steadily increasing lifespan, neurodegenerative diseases among elderly present significant therapeutic and socio-economic challenge. A properly balanced diet microbiome diversity have been receiving attention as targets for interventions in neurodegeneration. Microbiota may affect cognitive function, neuronal survival death, gut dysbiosis was identified Parkinson’s disease (PD). Tryptophan (Trp), an essential amino acid, is degraded by microbiota hosts numerous compounds with immune- neuromodulating properties. This broad narrative review presents data supporting concept that microbiota, Trp-kynurenine (KYN) pathway aryl hydrocarbon receptors (AhRs) form triad involved PD. disturbed gut–brain axis allows bidirectional spread pro-inflammatory molecules α-synuclein, which contribute to development/progression disease. We suggest peripheral levels kynurenines AhR ligands are strongly linked Trp metabolism should be studied together composition microbiota. Such approach can clearly delineate sub-populations PD patients manifesting microbiota–Trp-KYN–brain triad, who would benefit from modifications metabolism. Analyses microbiome, Trp-KYN metabolites signaling shed light on mechanisms intestinal distress identify new diagnosis treatment early-stage Therapeutic based combination well-defined food regimen, probiotics seem potential require further experimental clinical research.

Language: Английский

Citations

13

Circulating B vitamins metabolites in depressive disorders - connections with the microbiota-gut-brain axis DOI

Wiktor Śliwiński,

Oliwia Gawlik-Kotelnicka

Behavioural Brain Research, Journal Year: 2024, Volume and Issue: 472, P. 115145 - 115145

Published: July 9, 2024

Language: Английский

Citations

11

The Kynurenine Pathway in Gut Permeability and Inflammation DOI Creative Commons
Rowan Kearns

Inflammation, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 10, 2024

Language: Английский

Citations

5

Gut Microbiome Modulation of Glutamate Dynamics: Implications for Brain Health and Neurotoxicity DOI Open Access
Benjamin F. Gruenbaum, Kiran S. Merchant, Alexander Zlotnik

et al.

Nutrients, Journal Year: 2024, Volume and Issue: 16(24), P. 4405 - 4405

Published: Dec. 22, 2024

The gut–brain axis plays an integral role in maintaining overall health, with growing evidence suggesting its impact on the development of various neuropsychiatric disorders, including depression. This review explores complex relationship between gut microbiota and glutamate (Glu) regulation, highlighting effect brain particularly context depression following certain neurological insults. We discuss how microbial populations can either facilitate or limit Glu uptake, influencing bioavailability predisposing to neuroinflammation neurotoxicity. Additionally, we examine metabolites their influence blood–brain barrier neurotransmitter systems involved mood regulation. therapeutic potential microbiome-targeted interventions, such as fecal transplantation, is also highlighted. While much research has explored major depressive disorders other diseases, contribution post-neurological remains underexplored. Future should focus explaining mechanisms linking outcomes, conditions post-stroke depression, post-traumatic brain-injury epilepsy-associated Systematic reviews human clinical studies are needed establish causal relationships assess efficacy therapies improving sequalae after

Language: Английский

Citations

4

Neuroglia and the microbiota-gut-brain axis DOI
H. Blair, Lorena Morales, John F. Cryan

et al.

Handbook of clinical neurology, Journal Year: 2025, Volume and Issue: unknown, P. 171 - 196

Published: Jan. 1, 2025

Language: Английский

Citations

0

Aframomum melegueta mitigates seizure severity and neuroinflammation via gut-brain axis modulation in PTZ-induced kindling DOI Creative Commons

Ebenezer Kwesi Biney,

Akwasi Oppong,

Kwabena Gyampo-Asare

et al.

Clinical Phytoscience, Journal Year: 2025, Volume and Issue: 11(1)

Published: March 26, 2025

Abstract Background This study investigates the anticonvulsant properties of Aframomum melegueta in pentylenetetrazole (PTZ)-induced kindling rats, emphasizing on its effects gut-brain axis, inflammatory pathways, and metabolomic profiles. Given established links between brain gut through bidirectional communication their collective role epilepsy pathophysiology, this research aims to explore therapeutic potential ethanolic extract (AM) modulating these interactions. Results PTZ (40 mg/kg) was given rats induce kindling. Animals also, underwent chronic drug treatments AM sodium valproate (VPA) which were administered during induction observed for stages seizure development. Inflammatory mediators, neurotransmitters, cortisol concentration assessed serum post-kindling using NMR-based metabolomics ELISA assays. Findings suggest that seizures less severe frequent treated rats. Pretreatment with at doses, 30, 100, 300 mg/kg delayed effect development ( P < 0.05). treatment also reversed neuroinflammatory changes by lowering p 0.0001) IL-6 TNF-α levels. In addition, profiling affected neurotransmitter synthesis glutamate as well serotonin, acetate, propionate cortisol, similar what VPA Conclusion Therefore, findings present may be useful management influence brain-gut axis suppressing inflammation other metabolic processes PTZ-induced

Language: Английский

Citations

0

Evaluating the impact of gut microbiota, circulating cytokines and plasma metabolites on febrile seizure risk in Mendelian randomization study DOI Creative Commons

Chenyue Zhao,

Huiqin Xue,

Min Guo

et al.

Scientific Reports, Journal Year: 2025, Volume and Issue: 15(1)

Published: April 19, 2025

Language: Английский

Citations

0

The Influence of the Probiotics, Ketogenic Diets, and Gut Microbiota on Epilepsy and Epileptic Models: A Comprehensive Review DOI

Parmida Shirzadi,

Parisa Farokh,

Sima Osouli Meinagh

et al.

Molecular Neurobiology, Journal Year: 2025, Volume and Issue: unknown

Published: May 2, 2025

Language: Английский

Citations

0

Gut brain axis and gut microbiome in glioblastoma. Associations, treatment and outcomes DOI Creative Commons
G. Nandita, Azeena Saleem, B. Roja

et al.

Medicine in Microecology, Journal Year: 2025, Volume and Issue: unknown, P. 100131 - 100131

Published: May 1, 2025

Language: Английский

Citations

0